CHF Solutions Submits Patent Application for Hemofiltration System for Rapid Clearing of Cytokines in COVID-19 patients EDEN PRAIRIE, Minn., April 09, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...

Endonovo Therapeutics seeks Intensive Care Unit Partners for Investigational Adjunctive Treatment for Severe Respiratory Inflammatory Complications for COVID-19 Patients. Los Angeles, CA, March 25, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announces the intent to distribute of SofPulse®...

Global Generic Oncology Sterile Injectables Market to Surpass US$ 23.4 Billion by 2025 - Coherent Market Insights SEATTLE, May 24, 2018 (GLOBE NEWSWIRE) -- The global generic oncology sterile injectable market was valued at US$ 9,838.0 million in 2017 and is projected to exhibit a CAGR of 11.4% over the...

Response to Novel Immune Therapy for Ulcerative Colitis Associated with Genetic and Immune Biomarkers VANCOUVER, British Columbia , Oct. 03, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...

Hemispherx Encouraged by Cytokine Biomarker Discovery Which May Lead to a Diagnostic for Chronic Fatigue Syndrome PHILADELPHIA, Aug. 04, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) said today that a new study led by a team of researchers from Stanford University may provide the basis for a...